BACKGROUND: This study was carried out to evaluate the economic burden of Parkinson's disease (PD) and factors independently associated with individual components of total cost in Singapore. METHODS: A consecutive sample of 195 patients with PD (mean age: 68.2, men: 51.8%) attending a tertiary neuroscience clinic were identified and interviewed using standardized questionnaires including a financial burden questionnaire, two Health Related Quality of Life (HRQoL) questionnaires and the Beck Depression Inventory questionnaire. RESULTS: Annual total cost of PD from a societal perspective was SGD11345 (USD10129) per patient, with direct cost accounted for 38.5% and indirect cost 61.5%. The main cost components for direct medical cost, direct non-medical cost, and indirect cost was pharmacotherapy (50.4%), home care (76.1%), and productivity loss (97.9%), respectively. In multiple linear regression analysis, higher education, younger age and longer duration of PD were associated with higher total cost. CONCLUSIONS: Parkinson's disease exerts a considerable burden on patients, health care system and society in Singapore. As productivity loss accounts for a large share of the economic burden imposed by PD, treatments and health care programmes with potential for returning patients to higher productivity are urgently needed.
BACKGROUND: This study was carried out to evaluate the economic burden of Parkinson's disease (PD) and factors independently associated with individual components of total cost in Singapore. METHODS: A consecutive sample of 195 patients with PD (mean age: 68.2, men: 51.8%) attending a tertiary neuroscience clinic were identified and interviewed using standardized questionnaires including a financial burden questionnaire, two Health Related Quality of Life (HRQoL) questionnaires and the Beck Depression Inventory questionnaire. RESULTS: Annual total cost of PD from a societal perspective was SGD11345 (USD10129) per patient, with direct cost accounted for 38.5% and indirect cost 61.5%. The main cost components for direct medical cost, direct non-medical cost, and indirect cost was pharmacotherapy (50.4%), home care (76.1%), and productivity loss (97.9%), respectively. In multiple linear regression analysis, higher education, younger age and longer duration of PD were associated with higher total cost. CONCLUSIONS:Parkinson's disease exerts a considerable burden on patients, health care system and society in Singapore. As productivity loss accounts for a large share of the economic burden imposed by PD, treatments and health care programmes with potential for returning patients to higher productivity are urgently needed.
Authors: Tânia M Bovolenta; Sônia Maria Cesar de Azevedo Silva; Roberta Arb Saba; Vanderci Borges; Henrique Ballalai Ferraz; Andre C Felicio Journal: Parkinsons Dis Date: 2017-03-05
Authors: Christopher Kruse; Sabrina Kretschmer; Anna Lipinski; Malte Verheyen; David Mengel; Monika Balzer-Geldsetzer; Stefan Lorenzl; Carmen Richinger; Christian Schmotz; Lars Tönges; Dirk Woitalla; Stephan Klebe; Anette Schrag; Richard Dodel Journal: Pharmacoeconomics Date: 2021-03-19 Impact factor: 4.981
Authors: Jacki Liddle; David Ireland; Simon J McBride; Sandra G Brauer; Leanne M Hall; Hang Ding; Mohan Karunanithi; Paul W Hodges; Deborah Theodoros; Peter A Silburn; Helen J Chenery Journal: JMIR Mhealth Uhealth Date: 2014-03-12 Impact factor: 4.773
Authors: Tânia M Bovolenta; Sônia Maria Cesar de Azevedo Silva; Roberta Arb Saba; Vanderci Borges; Henrique Ballalai Ferraz; Andre C Felicio Journal: Clin Interv Aging Date: 2017-12-14 Impact factor: 4.458